tiprankstipranks
Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Want to see INTS full AI Analyst Report?

Compare Intensity Therapeutics, Inc. (INTS) vs. Competitors

252 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Intensity Therapeutics, Inc.
$4.27
$13.39M
-0.85
-40.25%
2 Buy
0 Hold
0 Sell
Moderate Buy
Cellectar Biosciences
$2.54
$22.40M
-0.52
-52.41%
3 Buy
0 Hold
0 Sell
Strong Buy
PDS Biotechnology
$0.22
$12.31M
-0.34
-81.97%
1 Buy
0 Hold
0 Sell
Moderate Buy
GT Biopharma
$0.29
$10.87M
-0.06
-74.06%
1 Buy
0 Hold
0 Sell
Moderate Buy
Celularity
$0.80
$48.63M
-0.46
-28.81%
Senti Biosciences
$0.39
$10.36M
-0.19
-75.94%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INTS
Intensity Therapeutics, Inc.
4.10
-3.18
-43.66%
CLRB
Cellectar Biosciences
2.37
-2.66
-52.88%
PDSB
PDS Biotechnology
0.22
-0.95
-81.20%
GTBP
GT Biopharma
0.24
-0.62
-72.01%
CELU
Celularity
1.68
-0.43
-20.38%
SNTI
Senti Biosciences
0.33
-0.99
-74.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts